LinkedIn Profile

Access New Leaf Venture Partners historical Linkedin company profile data on number of followers, employee headcount and more
Ticker Symbol Entity Name As Of Date Company Name Followers Employees on Linkedin Link Industry Date Added Date Updated Description Website Specialities Logo HQ.Street HQ.City HQ.State HQ.Country HQ.Postal GICS Sector GICS Industry
private:newleafventurepartners 84602 May 30th, 2019 12:00AM New Leaf Venture Partners 1.3K 25.00 Open Venture Capital & Private Equity May 30th, 2019 01:58PM May 30th, 2019 01:58PM We are currently investing out of two vehicles – NLV-III for venture investments and NLV Growth-I for private and public growth-stage biopharmaceuticals investments – and actively managing our fully committed portfolios – NLV-I and NLV-II – to advance the possibilities of healthcare by building the most innovative businesses that develop clinically important and commercially attractive healthcare solutions. NLVP was formed in 2005, when the healthcare team spun out of the Sprout Group. The NLVP team has been built over the last two decades and managed healthcare technology portfolios in four Sprout funds and four New Leaf funds. We partner with companies across all phases, from startup to public offerings, as we look to invest in visionary teams, businesses at the forefront of biology and innovation, and disruptive healthcare technologies across the entire healthcare system. And we share our broad perspectives, decades of experience and deep domain expertise to help our portfolio navigate the complexity of the healthcare industry. We have invested over $2 billion in over 150 companies through the NLVP and Sprout funds. We have had 38 companies taken public with 18 billion dollar companies. Open Biopharmaceuticals, Healthcare Technology (Information Convergence), Medical Devices Open 7 Times Square, Suite 3502 New York NY US 10036 Financial Services
private:newleafventurepartners 84602 Mar 26th, 2018 12:00AM New Leaf Venture Partners 1.2K 26.00 Open Venture Capital & Private Equity Mar 26th, 2018 05:19PM Mar 26th, 2018 05:19PM Open Financial Services
private:newleafventurepartners 84602 Feb 17th, 2018 12:00AM New Leaf Venture Partners 1.1K 26.00 Open Venture Capital & Private Equity Feb 17th, 2018 02:25PM Feb 17th, 2018 02:25PM We are currently investing out of two vehicles – NLV-III for venture investments and NLV Growth-I for private and public growth-stage biopharmaceuticals investments – and actively managing our fully committed portfolios – NLV-I and NLV-II – to advance the possibilities of healthcare by building the most innovative businesses that develop clinically important and commercially attractive healthcare solutions. NLVP was formed in 2005, when the healthcare team spun out of the Sprout Group. The NLVP team has been built over the last two decades and managed healthcare technology portfolios in four Sprout funds and four New Leaf funds. We partner with companies across all phases, from startup to public offerings, as we look to invest in visionary teams, businesses at the forefront of biology and innovation, and disruptive healthcare technologies across the entire healthcare system. And we share our broad perspectives, decades of experience and deep domain expertise to help our portfolio navigate the complexity of the healthcare industry. We have invested over $2 billion in over 150 companies through the NLVP and Sprout funds. We have had 38 companies taken public with 18 billion dollar companies. Financial Services
private:newleafventurepartners 84602 Feb 16th, 2018 12:00AM New Leaf Venture Partners 1.1K 26.00 Open Venture Capital & Private Equity Feb 16th, 2017 08:15AM Feb 16th, 2017 08:15AM We are currently investing out of two vehicles – NLV-III for venture investments and NLV Growth-I for private and public growth-stage biopharmaceuticals investments – and actively managing our fully committed portfolios – NLV-I and NLV-II – to advance the possibilities of healthcare by building the most innovative businesses that develop clinically important and commercially attractive healthcare solutions. NLVP was formed in 2005, when the healthcare team spun out of the Sprout Group. The NLVP team has been built over the last two decades and managed healthcare technology portfolios in four Sprout funds and four New Leaf funds. We partner with companies across all phases, from startup to public offerings, as we look to invest in visionary teams, businesses at the forefront of biology and innovation, and disruptive healthcare technologies across the entire healthcare system. And we share our broad perspectives, decades of experience and deep domain expertise to help our portfolio navigate the complexity of the healthcare industry. We have invested over $2 billion in over 150 companies through the NLVP and Sprout funds. We have had 38 companies taken public with 18 billion dollar companies. Financial Services
private:newleafventurepartners 84602 Feb 15th, 2018 12:00AM New Leaf Venture Partners 1.1K 26.00 Open Venture Capital & Private Equity Feb 15th, 2017 10:07AM Feb 15th, 2017 10:07AM We are currently investing out of two vehicles – NLV-III for venture investments and NLV Growth-I for private and public growth-stage biopharmaceuticals investments – and actively managing our fully committed portfolios – NLV-I and NLV-II – to advance the possibilities of healthcare by building the most innovative businesses that develop clinically important and commercially attractive healthcare solutions. NLVP was formed in 2005, when the healthcare team spun out of the Sprout Group. The NLVP team has been built over the last two decades and managed healthcare technology portfolios in four Sprout funds and four New Leaf funds. We partner with companies across all phases, from startup to public offerings, as we look to invest in visionary teams, businesses at the forefront of biology and innovation, and disruptive healthcare technologies across the entire healthcare system. And we share our broad perspectives, decades of experience and deep domain expertise to help our portfolio navigate the complexity of the healthcare industry. We have invested over $2 billion in over 150 companies through the NLVP and Sprout funds. We have had 38 companies taken public with 18 billion dollar companies. Financial Services
private:newleafventurepartners 84602 Feb 14th, 2018 12:00AM New Leaf Venture Partners 1.1K 26.00 Open Venture Capital & Private Equity Feb 14th, 2017 01:50PM Feb 14th, 2017 01:50PM We are currently investing out of two vehicles – NLV-III for venture investments and NLV Growth-I for private and public growth-stage biopharmaceuticals investments – and actively managing our fully committed portfolios – NLV-I and NLV-II – to advance the possibilities of healthcare by building the most innovative businesses that develop clinically important and commercially attractive healthcare solutions. NLVP was formed in 2005, when the healthcare team spun out of the Sprout Group. The NLVP team has been built over the last two decades and managed healthcare technology portfolios in four Sprout funds and four New Leaf funds. We partner with companies across all phases, from startup to public offerings, as we look to invest in visionary teams, businesses at the forefront of biology and innovation, and disruptive healthcare technologies across the entire healthcare system. And we share our broad perspectives, decades of experience and deep domain expertise to help our portfolio navigate the complexity of the healthcare industry. We have invested over $2 billion in over 150 companies through the NLVP and Sprout funds. We have had 38 companies taken public with 18 billion dollar companies. Financial Services
private:newleafventurepartners 84602 Feb 13th, 2018 12:00AM New Leaf Venture Partners 1.1K 26.00 Open Venture Capital & Private Equity Feb 13th, 2017 04:11PM Feb 13th, 2017 04:11PM We are currently investing out of two vehicles – NLV-III for venture investments and NLV Growth-I for private and public growth-stage biopharmaceuticals investments – and actively managing our fully committed portfolios – NLV-I and NLV-II – to advance the possibilities of healthcare by building the most innovative businesses that develop clinically important and commercially attractive healthcare solutions. NLVP was formed in 2005, when the healthcare team spun out of the Sprout Group. The NLVP team has been built over the last two decades and managed healthcare technology portfolios in four Sprout funds and four New Leaf funds. We partner with companies across all phases, from startup to public offerings, as we look to invest in visionary teams, businesses at the forefront of biology and innovation, and disruptive healthcare technologies across the entire healthcare system. And we share our broad perspectives, decades of experience and deep domain expertise to help our portfolio navigate the complexity of the healthcare industry. We have invested over $2 billion in over 150 companies through the NLVP and Sprout funds. We have had 38 companies taken public with 18 billion dollar companies. Financial Services
private:newleafventurepartners 84602 Feb 12th, 2018 12:00AM New Leaf Venture Partners 1.1K 26.00 Open Venture Capital & Private Equity Feb 12th, 2017 04:15AM Feb 12th, 2017 04:15AM We are currently investing out of two vehicles – NLV-III for venture investments and NLV Growth-I for private and public growth-stage biopharmaceuticals investments – and actively managing our fully committed portfolios – NLV-I and NLV-II – to advance the possibilities of healthcare by building the most innovative businesses that develop clinically important and commercially attractive healthcare solutions. NLVP was formed in 2005, when the healthcare team spun out of the Sprout Group. The NLVP team has been built over the last two decades and managed healthcare technology portfolios in four Sprout funds and four New Leaf funds. We partner with companies across all phases, from startup to public offerings, as we look to invest in visionary teams, businesses at the forefront of biology and innovation, and disruptive healthcare technologies across the entire healthcare system. And we share our broad perspectives, decades of experience and deep domain expertise to help our portfolio navigate the complexity of the healthcare industry. We have invested over $2 billion in over 150 companies through the NLVP and Sprout funds. We have had 38 companies taken public with 18 billion dollar companies. Financial Services
private:newleafventurepartners 84602 Feb 11th, 2018 12:00AM New Leaf Venture Partners 1.1K 26.00 Open Venture Capital & Private Equity Feb 11th, 2017 05:35AM Feb 11th, 2017 05:35AM We are currently investing out of two vehicles – NLV-III for venture investments and NLV Growth-I for private and public growth-stage biopharmaceuticals investments – and actively managing our fully committed portfolios – NLV-I and NLV-II – to advance the possibilities of healthcare by building the most innovative businesses that develop clinically important and commercially attractive healthcare solutions. NLVP was formed in 2005, when the healthcare team spun out of the Sprout Group. The NLVP team has been built over the last two decades and managed healthcare technology portfolios in four Sprout funds and four New Leaf funds. We partner with companies across all phases, from startup to public offerings, as we look to invest in visionary teams, businesses at the forefront of biology and innovation, and disruptive healthcare technologies across the entire healthcare system. And we share our broad perspectives, decades of experience and deep domain expertise to help our portfolio navigate the complexity of the healthcare industry. We have invested over $2 billion in over 150 companies through the NLVP and Sprout funds. We have had 38 companies taken public with 18 billion dollar companies. Financial Services
private:newleafventurepartners 84602 Feb 10th, 2018 12:00AM New Leaf Venture Partners 1.1K 26.00 Open Venture Capital & Private Equity Feb 10th, 2017 06:43AM Feb 10th, 2017 06:43AM We are currently investing out of two vehicles – NLV-III for venture investments and NLV Growth-I for private and public growth-stage biopharmaceuticals investments – and actively managing our fully committed portfolios – NLV-I and NLV-II – to advance the possibilities of healthcare by building the most innovative businesses that develop clinically important and commercially attractive healthcare solutions. NLVP was formed in 2005, when the healthcare team spun out of the Sprout Group. The NLVP team has been built over the last two decades and managed healthcare technology portfolios in four Sprout funds and four New Leaf funds. We partner with companies across all phases, from startup to public offerings, as we look to invest in visionary teams, businesses at the forefront of biology and innovation, and disruptive healthcare technologies across the entire healthcare system. And we share our broad perspectives, decades of experience and deep domain expertise to help our portfolio navigate the complexity of the healthcare industry. We have invested over $2 billion in over 150 companies through the NLVP and Sprout funds. We have had 38 companies taken public with 18 billion dollar companies. Financial Services

Request a demo to view additional historical data, and much more.

Make fast
queries

No longer rely on engineers to access data; build and share queries with intuitive tools, and derive insights in real time.

Bookmark queries with your team

Save and share custom queries using a private bookmarking feature, accessible to your whole team.

Be first to know with alerts

Scan data points across millions of companies and receive emails when relevant metrics cross critical thresholds.

Visualize data for quick insights

Create custom keyword-based word clouds, charts, and advanced visualizations to quickly analyze the data.

Map competitor locations

Analyze competitor presence and growth over time by overlaying store locations with the Nearby Competitor feature.